PA
CEMI

Pinnacle Associates’s Chembio diagnostics, Inc. CEMI Stock Holding History

Pinnacle Associates’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-18,000
Closed -$92K – 716
2020
Q1 		$92K Buy
+18,000
New +$72.8K ﹤0.01% 632

Other funds holding CEMI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pinnacle Associates's CEMI Position: Q2 2020 in Review

Pinnacle Associates sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2020, closing a stake of 18,000 shares — an estimated $92K sold.

Pinnacle Associates first reported a position in CEMI in Q1 2020 and held it in 1 quarter. The position peaked at $92K in Q1 2020. 76 funds tracked by Wall St. Rank hold CEMI as of Q2 2020.

  • Pinnacle Associates reported no remaining Chembio diagnostics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Pinnacle Associates sold 18,000 Chembio diagnostics, Inc. shares in Q2 2020, an estimated $92K.
  • Pinnacle Associates first reported a position in Chembio diagnostics, Inc. in Q1 2020 and held it in 1 quarter.
  • Pinnacle Associates's Chembio diagnostics, Inc. position peaked at $92K in Q1 2020.
  • 76 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2020.

Based on Pinnacle Associates's 13F filing for Q2 2020, filed 14 Aug 2020.